Zeng E - Search Results

1

Ferroptosis in antitumor therapy: Unraveling regulatory mechanisms and immunogenic potential.

Zhang T, Zeng X, Zeng E, Wang H. Zhang T, et al. Among authors: zeng e, zeng x. Int Immunopharmacol. 2024 Jun 15;134:112203. doi: 10.1016/j.intimp.2024.112203. Epub 2024 May 4. Int Immunopharmacol. 2024. PMID: 38705030 Review.

2

Apoptosis dysfunction: unravelling the interplay between ZBP1 activation and viral invasion in innate immune responses.

Zhan J, Wang J, Liang Y, Wang L, Huang L, Liu S, Zeng X, Zeng E, Wang H. Zhan J, et al. Among authors: zeng e, zeng x. Cell Commun Signal. 2024 Feb 24;22(1):149. doi: 10.1186/s12964-024-01531-y. Cell Commun Signal. 2024. PMID: 38402193 Free PMC article. Review.

3

APOE as potential biomarkers of moyamoya disease.

Wu H, Xu J, Sun J, Duan J, Xiao J, Ren Q, Zhou P, Yan J, Li Y, Xiong X, Zeng E. Wu H, et al. Among authors: zeng e. Front Neurol. 2023 May 9;14:1156894. doi: 10.3389/fneur.2023.1156894. eCollection 2023. Front Neurol. 2023. PMID: 37228412 Free PMC article.

4

Dihydroartemisinin treatment exhibits antitumor effects in glioma cells through induction of apoptosis.

Xu CH, Liu Y, Xiao LM, Guo CG, Zheng SY, Zeng EM, Li DH. Xu CH, et al. Mol Med Rep. 2017 Dec;16(6):9528-9532. doi: 10.3892/mmr.2017.7832. Epub 2017 Oct 19. Mol Med Rep. 2017. PMID: 29152657

5

MMP12 is a potential therapeutic target for Adamantinomatous craniopharyngioma: Conclusions from bioinformatics analysis and in vitro experiments.

Li M, Zhou L, Li S, Fang L, Yang L, Wu X, Yang C, Bao Y, Lan S, Tong Z, Zheng S, Tang B, Zeng E, Xie S, Chen C, Hong T. Li M, et al. Among authors: zeng e. Oncol Lett. 2021 Jul;22(1):536. doi: 10.3892/ol.2021.12797. Epub 2021 May 19. Oncol Lett. 2021. PMID: 34084216 Free PMC article.

6

Biological Functions of TNKS1 and Its Relationship with Wnt/β-Catenin Pathway in Astrocytoma.

Chen M, Tang B, Xie S, Yan J, Yang L, Zhou X, Zeng E. Chen M, et al. Among authors: zeng e. Onco Targets Ther. 2019 Dec 11;12:10841-10850. doi: 10.2147/OTT.S206142. eCollection 2019. Onco Targets Ther. 2019. PMID: 31849489 Free PMC article.

7

MicroRNA-181 inhibits the proliferation, drug sensitivity and invasion of human glioma cells by targeting Selenoprotein K (SELK).

Xu CH, Xiao LM, Zeng EM, Chen LK, Zheng SY, Li DH, Liu Y. Xu CH, et al. Am J Transl Res. 2019 Oct 15;11(10):6632-6640. eCollection 2019. Am J Transl Res. 2019. PMID: 31737213 Free PMC article.

8

Erratum: MicroRNA-181 inhibits the proliferation, drug sensitivity and invasion of human glioma cells by targeting Selenoprotein K (SELK).

Xu CH, Xiao LM, Zeng EM, Chen LK, Zheng SY, Li DH, Liu Y. Xu CH, et al. Am J Transl Res. 2021 Aug 15;13(8):9914-9917. eCollection 2021. Am J Transl Res. 2021. PMID: 34540128 Free PMC article.

9

Long non-coding RNA LINC00526 represses glioma progression via forming a double negative feedback loop with AXL.

Yan J, Xu C, Li Y, Tang B, Xie S, Hong T, Zeng E. Yan J, et al. Among authors: zeng e. J Cell Mol Med. 2019 Aug;23(8):5518-5531. doi: 10.1111/jcmm.14435. Epub 2019 Jun 26. J Cell Mol Med. 2019. PMID: 31240814 Free PMC article.

10

Long Noncoding RNA LINC00526 Represses Glioma Progression via Regulating miR-5581-3p/BEX1.

Yan J, Li Y, Xu C, Tang B, Xie S, Hong T, Zeng E. Yan J, et al. Among authors: zeng e. J Oncol. 2021 Feb 4;2021:8171250. doi: 10.1155/2021/8171250. eCollection 2021. J Oncol. 2021. PMID: 33613672 Free PMC article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

475 results

Search Page

Filters